Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumor Vaccination and rhIL-7 in Pediatric Solid Tumors
NCT00923351Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2007
- Primary completion
- Aug 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human interleukin-7 in Ewing sarcoma, rhabdomyosarcoma (RMS), neuroblastoma, synovial sarcoma (SS), desmoplastic small round cell tumor (DSRCT), sponsored by National Cancer Institute. Started Jun 2007; status: completed.
02
Drugs
recombinant human interleukin-7
03
Conditions
Ewing sarcomarhabdomyosarcoma (RMS)neuroblastomasynovial sarcoma (SS)desmoplastic small round cell tumor (DSRCT)
Beyond the preview
Go deeper on NCT00923351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00923351.